← Leaderboards
Gabrelle Lavender Hackman
University Of Texas At Austin
$117,901
Attributed
$117,901
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $40.1K · FY2023–25$50K$37.5K$25K$12.5K$0
'23
'24
'25
Funding mix
By agency
NIH$117,901 · 1
By mechanism
F31$117,901 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas At Austin
Same institution · by research overlap
- John Digiovanni$26,040,423
- Guangbin Dong$6,978,172
- Stefano Tiziani$2,053,872
- George Georgiou Georgiou$8,894,674
- Everett Stone$5,907,133
Others in their field
Other Rising Stars on “Castration”
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Remi Adelaiye-Ogala · State University Of New York At Buffalo$2,864,216
- Akash Patnaik · University Of Chicago$2,630,502
- Russell K. Pachynski · Washington University$2,036,989
- Justin Michael Drake · Astrin Biosciences, Inc.$1,931,918
- Dawid Grzegorz Nowak · Weill Medical Coll Of Cornell Univ$1,899,979
Research focus
CastrationCell LineAcquired Drug ResistanceAdvanced Prostate CancerAllograftingAndrogen Deprivation TherapyAlpha KetoglutarateAndrogensAndrogen SensitiveAntiporterAutomobile DrivingBiomassBoneBrainBypassCancer CellCancer DiagnosisCancer Drug ResistanceCancer EtiologyCancer SubtypesCancer TypeCarbon SkeletonCaringCell Proliferation
Grant awards (3)
Targeting Metabolic Vulnerabilities with Synergistic Therapeutic Agents for Treatment of Metastatic Castration-Resistant Prostate Cancer.$40,103
F31 · FY2025 · CA · contact PI
Targeting Metabolic Vulnerabilities with Synergistic Therapeutic Agents for Treatment of Metastatic Castration-Resistant Prostate Cancer.$39,539
F31 · FY2024 · CA · contact PI
Targeting Metabolic Vulnerabilities with Synergistic Therapeutic Agents for Treatment of Metastatic Castration-Resistant Prostate Cancer.$38,259
F31 · FY2023 · CA · contact PI